Quarterly report pursuant to Section 13 or 15(d)

Net Loss per Common Share (Tables)

v3.20.2
Net Loss per Common Share (Tables)
9 Months Ended
Sep. 30, 2020
Earnings Per Share [Abstract]  
Antidilutive Securities Excluded From Computation of Diluted Net Loss per Common Share

The following table represents the potential common shares issuable pursuant to outstanding securities as of the related period end dates that were excluded from the computation of diluted net loss per common share, as their inclusion would have an antidilutive effect:

 

 

As of September 30,

 

 

2020

 

 

2019

 

Unvested RSUs

 

3,003,142

 

 

 

2,001,218

 

Vested and unvested options

 

8,205,062

 

 

 

7,364,588

 

ESPP share purchase rights

 

107,970

 

 

 

75,893

 

Total

 

11,316,174

 

 

 

9,441,699